DeBakey Heart & Vascular Center

Medicine & Life Sciences

1. Coronary Vessels 100%
2. Coronary Artery Disease 96%
3. Cardiovascular Diseases 90%
4. Heart Failure 85%
5. Atherosclerosis 78%
6. Mortality 74%
7. Calcium 68%
8. Transcatheter Aortic Valve Replacement 64%
9. Myocardial Infarction 63%
10. Therapeutics 50%
11. Lipids 49%
12. Aortic Valve 47%
13. Computed Tomography Angiography 46%
14. Heart 46%
15. Registries 46%
16. Echocardiography 44%
17. Blood Vessels 42%
18. Hydroxymethylglutaryl-CoA Reductase Inhibitors 42%
19. Cholesterol 42%
20. Transplants 40%
21. Heart-Assist Devices 39%
22. Percutaneous Coronary Intervention 38%
23. Lipoproteins 35%
24. Coronary Disease 34%
25. Stents 33%
26. Stroke 33%
27. HDL Lipoproteins 32%
28. Exercise 32%
29. Peripheral Arterial Disease 31%
30. Hypertension 30%
31. Equipment and Supplies 29%
32. Ischemia 28%
33. Mitral Valve 28%
34. Angiography 28%
35. Blood Pressure 28%
36. Hemodynamics 28%
37. LDL Lipoproteins 27%
38. Population 27%
39. Confidence Intervals 27%
40. Magnetic Resonance Spectroscopy 27%
41. Endothelial Cells 27%
42. Thrombosis 27%
43. Tomography 26%
44. Atrial Fibrillation 26%
45. Aortic Valve Stenosis 26%
46. LDL Cholesterol 26%
47. Acute Coronary Syndrome 26%
48. Perfusion 24%
49. Apolipoprotein A-I 24%
50. Mitral Valve Insufficiency 24%
51. Coronary Angiography 24%
52. Safety 24%
53. Cardiology 23%
54. Surgical Instruments 23%
55. Cardiomyopathies 23%
56. Hypertrophic Cardiomyopathy 22%
57. Pathologic Constriction 22%
58. HDL Cholesterol 22%
59. Placebos 22%
60. Guidelines 22%
61. Myocardium 21%
62. Heart Transplantation 21%
63. Stroke Volume 21%
64. Apolipoproteins 21%
65. Left Ventricular Function 21%
66. Meta-Analysis 21%
67. Myocardial Perfusion Imaging 20%
68. Platelet Glycoprotein GPIIb-IIIa Complex 20%
69. Odds Ratio 19%
70. Magnetic Resonance Imaging 19%
71. Angioplasty 19%
72. Incidence 19%
73. Health 19%
74. Cardiac Arrhythmias 18%
75. Proteins 18%
76. Blood Platelets 18%
77. Risk Assessment 18%
78. Nitric Oxide 18%
79. Thorax 18%
80. Inflammation 18%
81. Single-Photon Emission-Computed Tomography 18%
82. Veins 18%
83. Myocardial Ischemia 17%
84. N,N-dimethylarginine 17%
85. Morbidity 17%
86. Coronary Artery Bypass 17%
87. Randomized Controlled Trials 17%
88. Triglycerides 17%
89. Heparin 17%
90. Atherosclerotic Plaques 17%
91. Heart Ventricles 17%
92. Heart Diseases 17%
93. Arteries 17%
94. Hypercholesterolemia 17%
95. Primary Prevention 17%
96. Abciximab 17%
97. Phospholipids 16%
98. Neoplasms 16%
99. Fibrosis 16%
100. Clinical Trials 16%